Guided chemotherapy injection for pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether injecting chemotherapy directly into the tumor during an endoscopic ultrasound (a thin tube passed down your throat) can help treat locally advanced pancreatic cancer that hasn't spread elsewhere. It is for people who are newly diagnosed and have not had prior treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been newly diagnosed with pancreatic cancer confirmed by a biopsy.
- Your cancer is locally advanced, meaning it has not spread to other organs but may still be possible to remove with surgery.
- You are in good enough health to be up and active (ECOG 0 or 1), meaning you can do light work or are fully active.
- You have not received prior surgery, chemotherapy, or radiation for this pancreatic cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to treat pancreatic cancer that has spread to nearby tissues but not to distant organs. It uses a tailored plan that may include chemotherapy and possibly surgery. The goal is to see if this personalized approach helps people live longer and better.
This trial tests whether adding focused ultrasound (IMD10) to standard chemotherapy helps treat pancreatic cancer that is borderline or locally advanced and cannot be removed by surgery right away. It may shrink the tumor enough to allow surgery later.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
This trial tests a new drug called NRT6008 combined with standard chemotherapy for pancreatic cancer that cannot be surgically removed. The goal is to see if adding this new drug makes the chemotherapy work better and is safe.
This trial tests a new cell therapy (BGT007H) for people with advanced pancreatic cancer that has not responded to earlier treatments. The goal is to see if it is safe and can help shrink or control the cancer.
This trial tests whether giving targeted radiation (SBRT) followed by an experimental immunotherapy drug injected directly into the tumor is safe for people with locally advanced pancreatic cancer. It aims to shrink the tumor and help your immune system fight it.
Hear when a new Locally Advanced Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.